The Academy of Pharmaceutical Sciences
'Promoting the pharmaceutical sciences'


Faron Pharmaceuticals recruits first patient for new Traumakine trial.....           Modus Therapeutics raises £2.9m to support further development of sevuparin for SCD.....           Chi-Med starts phase II study of savolitinib in pulmonary sarcomatoid carcinoma.....           AstraZeneca's Lynparza meets primary endpoint in breast cancer study.....           Daiichi Sankyo, ArQule?s tivantinib fails to meet primary end point in liver cancer study.....           Momenta announces FDA warning letter to contracted Glatopa?s fill/finish manufacturer.....           Arix Bioscience raises £100m in IPO.....           FiercePharmaAsia: PRA and Takeda?s Japan JV, Sun?s shrunken profits, ASLAN?s positive varlitinib data.....           Pharma outcast Shkreli riles up protesters at Boston speaking events.....           AZ looks to extend PARP lead with solid Lynparza breast cancer data.....           Pfizer's Xeljanz goes head-to-head with AbbVie's Humira in RA study.....           Takeda acquires Ariad Pharmaceuticals.....           Valeant gets FDA approval for SILIQ to treat moderate-to-severe plaque psoriasis.....           Sought-after Stada confirms unnamed third suitor.....           Congressional pharma critic Cummings hits back after Trump's erratic presser.....           With Siliq approval, can Amgen and AZ's trash become Valeant's treasure?.....           Cheaper drugs from Canada? Pharma despises the idea, but top senators are pushing HHS chief to try it.....           Pfizer's solo Xeljanz can't match AbbVie's Humira in big RA head-to-head miss.....           Trump's 'not going to back down' from vaccine safety commission, RFK says after new White House talks.....           What's wrong with Sanofi's dealmaking approach? To hear Actelion tell it, plenty.....           What innovation? PhRMA slams Marathon after $89K pricing scandal.....           Pharma critic Cummings hits back after Trump's erratic presser.....           Ardelyx's tenapanor shows significant effect in hyperphosphatemia in phase 3 trial.....           X-Chem, Janssen extend inflammatory disease collaboration.....           Versant Ventures launches biotechnology firm Jecure Therapeutics.....           Pfizer, Flynn appeal against UK regulator's £89.4m fine for epilepsy drug price hike.....           Bayer turns America?s 'Smiths' into aspirin-carrying heart attack heroes.....           Merck recruits football star Jim Kelly to help head-and-neck cancer patients craft their 'game plans'.....           AMAG to hire 150 new sales reps to tout newly licensed women's health med Intrarosa.....           Pharma lobby launches crusade against Cuomo's 'flawed' drug pricing plan in NY.....           Pfizer appeals record fine from U.K. regulator tied to 2,600% drug price hike.....           Would Pfizer, Roche or Novartis megamerge with BMS? Rumors say they're crunching numbers now.....           Genentech lobbyist's life and death makes pharma waves.....           NICE shoots down AbbVie's wannabe leukemia blockbuster Venclexta.....           Merck halts clinical trial of Alzheimer's drug.....           Horizon Discovery signs master service deal with top three global pharmaceutical firm.....           ViiV Healthcare unveils positive study results for two-drug regimen for HIV.....           Pfizer, GSK targeted for vaccine pricing in MSF Twitter spree.....           GSK looks for another OTC allergy crossover hit in newly launched Flonase Sensimist.....           That was fast: Days after launching a strategic review, Teva's eyeing a branded generics sale or spinoff.....           If copies of Teva's Copaxone hit, oral MS rivals could be the real threat.....           As Trump talks 'America First' on trade, pharma presses its global patent rights.....           EMA examines key Actelion med Uptravi following 5 patient deaths in France.....           Valeant, Ackman will split the bills for years-long Allergan shareholder suit.....           MSF renews pricing protests over Pfizer, GSK pneumonia shots.....           Sanofi agrees to divest five OTC products to Ipsen for EUR83m.....           Axovant's nelotanserin demonstrates treatment benefit in phase 2 dementia study.....           Daiichi Sankyo to close Japanese research subsidiary.....           Novimmune, LegoChem to collaborate on antibody drug conjugate research.....           Immunomedics, Seattle Genetics sign $2bn licensing deal for cancer drug.....           Diabetes drugs pop on January's TV ad spending list, but AbbVie's Humira stays at the top.....           Novartis expands Vivinda TV, offering docs digital access to medical conferences.....           Proxy fight survivor Stada entertains suitors for potential $3.7B buyout.....           Senator says drugmakers may be misusing FDA orphan drug rules?and costing taxpayers money.....           Can Roche's Herceptin-Perjeta combo expand yet again? Check the impending data.....           Allergan continues M&A spree with $2.5B deal to beef up aesthetics unit.....           Should Teva join the split-up club? With CEO gone and options open, analysts press for answers.....           Marathon halts launch of DMD drug as $89K price attracts Congressional heat.....           Immunomedics, Seattle Genetics sign $2bn licencing deal for cancer drug.....           German pharma company Stada confirms takeover bid from two firms.....           Tracon's lead product candidate fails in phase 2 study in brain cancer trial.....           Reckitt Benckiser to purchase Mead Johnson for $16.6bn.....           RSS NEWSFEED....
Welcome to
The Academy of
Pharmaceutical Sciences
 
The Academy of Pharmaceutical Sciences (APS) is the UK-based professional membership body for Pharmaceutical Scientists.

We represent individuals and organisations from around the globe, throughout their development, in the delivery of excellence in the Pharmaceutical Science sector.
 
 
PharmSci 2017 - first announcement

Tuesday 5 - Thursday 7 September 2017 at De Havilland Campus, University of Hertfordshire, Hatfield

The theme of the conference in 2017 is:
'Pharmaceutical Science without Borders'

The APS is pleased to announce Professor Abdul Basit as this year's Conference Science Chair.

Professor of Pharmaceutics at the School of Pharmacy, University College London, where he leads a research group investigating drug delivery to the gastrointestinal tract.

"I am delighted to be Chairing the 8th APS International PharmSci Conference 2017 at the University of Hertfordshire, where our focus this year is "Pharmaceutical Science without Borders". Pharmaceutical science transcends a multitude of borders - it is very much an international field, collaborative in nature and underpins medicines development. The healthcare challenges we face today are global, and cannot be addressed in isolation. Our aim in this conference is to connect, empower and inspire those of you across the pharmaceutical sciences sector and beyond; to broaden your research goals and horizons alongside showcasing pragmatic approaches to trouble-shooting/problem-solving in the pharmaceutical sciences. I look forward to welcoming you to what will no doubt be a fascinating and intellectually stimulating event."

You can become part of this conference now.

Reserve the date, suggest a topic, offer a poster presentation, reserve an exhibition space and many other opportunities. Please email info@apsgb.org.

Please also regularly check the PharmSci website for updates.
 

PharmSci 2016 Conference - Chair's review

The Chair of the Academy of Phamaceutical Sciences, Dr Linda Hakes, gives a brief review of the 7th APS International PharmSci Conference, held in Glasgow on 5-7 September 2016.

"2016 has come to an end and although I admit that I am probably biased, I think it was a fantastic three days. The venue, the Technology and Innovation Centre at Strathclyde University, was well equipped to handle the conference and the facilities are modern and efficient.

All of the conference sessions (as far as I could tell) were well attended and the plenary lectures were all excellent, covering topics ranging across the spectrum of pharmaceutical sciences, embracing chemistry, pharmacology, medical devices, formulation, pharmacokinetics and spectroscopy.

A highlight of the social side was the Civic Reception in the City Chambers, a magnificent building on George Square, where we were warmly welcomed by the Bailey Steward on behalf of the Lord Provost of Glasgow.

 

 

 

 

 

As always the Black Tie Dinner was a great success and we were pleased to have Prof. Sandy Florence as guest speaker. Again, the venue was truly impressive – the Barony Hall.

 

 

 

 


To sum up, I believe we enjoyed a conference full of good science, excellent networking opportunities, and highly enjoyable social events. If you weren’t there, why not make a note for next year –
Tuesday 5 - Thursday 7 September 2017 at the University of
Hertfordshire .

See you there!"

Latest News
APS 8th International PharmSci Conference 2017 Call for Abstracts
THURSDAY, 12 JANUARY 2017
. 'Pharmaceutical Sciences Without Borders’. Tuesday 5 – Thursday 7 September 2017 De Havilland Campus of the University of Hertfordshire in Hatfield. Call for Abstracts. Abstracts are invited for posters for APS International PharmSci 2017. This is one of the most exciting parts of the conference as it represents the presentation of the very latest pharmaceutical science research.. Abstracts on any aspect of the Pharmaceutical Sciences are welcomed and those with a particular emphasis on the theme of this year’s Conference, 'Pharmaceutical Sciences Without Borders’ are particularly appreciated. Details of the various subject categories, an abstract template and details of the entry process can be found here:. http://www.ukpharmsci.org/abstracts/default.asp. Please ensure abstracts are submitted online and comply with the Abstract Submission Template. Please note one or two page abstracts are welcomed providing they follow the template.. There will be prizes awarded for winning posters on each day of the Conference and authors of abstracts of particular interest will be invited to give podium presentations (15min). This is an excellent chance to get your science recognised at the UK’s premier Pharmaceutical Science Conference. The closing date for abstract submission is Friday 17th March 2017.. Abstracts will be made available to Conference registrants when the abstract author has registered for the Conference. We also intend to publish the abstracts in a journal after the Conference and authors not wishing to take up this opportunity are requested to indicate this where indicated when they submit their abstract.. Entrants in the Analytical Chemistry category may be eligible for the Geoffrey Phillips Analytical Science Award, subject to meeting the criteria, awarded by the Joint Pharmaceutical Analysis Group (JPAG). The purpose of the Award is to encourage the advancement of pharmaceutical analysis and to recognise contributions of emerging scientists reporting wholly or mainly their own work. The winner receives a prestigious award with a bursary of up to £1000 to attend a conference relevant to their area of interest.. http://www.jpag.org/?&sid=20170112135948802597&p=awards#award. Exhibitor Opportunities. The conference includes a large pharmaceutical sciences exhibition, which is open to large pharma companies, small and medium size enterprises (SMEs), contract research organisations (CROs) and technology suppliers. With one of the largest gatherings of pharmaceutical scientists in the UK, the conference offers a great opportunity to showcase your company.. For more information please contact us: info@apsgb.org or 0116 274 7351. .
APS Fellowships Announcement 2017
WEDNESDAY, 2 NOVEMBER 2016
Do you know someone who has made a significant contribution to Pharmaceutical Science?. The APS is calling for nominations of candidates to become Fellow or Eminent Fellow of the Academy of Pharmaceutical Sciences.. Nominees for Fellowship must be a member of APS (for at least one year) and have a proven track record in pharmaceutical science, as demonstrated by at least 15 peer-reviewed publications, patents or equivalent. This would include significant contributions to the development of products or medical devises within the pharmaceutical industry. Nominees must also have demonstrated leadership and peer recognition through invited lectures, conference leadership, mentoring of young scientists etc. Candidates may self-nominate and nominations must consist of a one-page summary of achievements accompanies by a CV.. Nominations for Eminent Fellowship may be submitted by any member of APS but self-nominations are not accepted. Nominees for Eminent Fellowship must have international recognition for their advocacy of science and have demonstrated leadership at international level. Nominations should consist of a one-page summary of achievements and an explanation of why Eminent Fellowship is justified, and be accompanied by a CV.. Nominations should be sent to info@apsgb.org by 1 March 2017.
APS 8th International PharmSci Conference 2017
TUESDAY, 1 NOVEMBER 2016
. Tuesday 5 - Thursday 7 September 2017 De Havilland Campus, University of Hertfordshire, Hatfield. The theme of the conference in 2017 is. 'Pharmaceutical Science without Borders'. The APS is pleased to announce Professor Abdul Basit as the Conference Science Chair Professor of Pharmaceutics at the School of Pharmacy, University College London, where he leads a research group investigating drug delivery to the gastrointestinal tract.. “I am delighted to be Chairing the 8th APS International PharmSci Conference 2017 at the University of Hertfordshire, where our focus this year is “Pharmaceutical Science without Borders”. Pharmaceutical science transcends a multitude of borders – it is very much an international field, collaborative in nature and underpins medicines development. The healthcare challenges we face today are global, and cannot be addressed in isolation. Our aim in this conference is to connect, empower and inspire those of you across the pharmaceutical sciences sector and beyond; to broaden your research goals and horizons alongside showcasing pragmatic approaches to trouble-shooting/problem-solving in the pharmaceutical sciences. I look forward to welcoming you to what will no doubt be a fascinating and intellectually stimulating event.”. . You can become part of this conference now,. Reserving the date, suggest a topic, offer a poster presentation, reserve an exhibition space and many other opportunities. Please email info@apsgb.org.. . . . . . .
APS thanks retiring Board members and welcomes Yvonne Perrie and Michael Leane as newly appointed Board members
TUESDAY, 4 OCTOBER 2016
At the AGM on 5 September, held during the PharmSci conference at the Technology and Innovation Centre at Strathclyde University, we formally thanked our two retiring Board members, Richard Storey and Claire Thompson, for all their hard work and support of APS over several years of service. Claire has been an enthusiastic Board member who has been a strong advocate for pharmaceutical science and has been very engaged in outreach to universities, students and young scientists. Richard Storey has served not only as a Board member but has also been our Treasurer for many years, a task which has had many challenges which he has managed in a calm and professional manner. We are very grateful to both of them and hope that they will remain active members and supporters of APS.. . At the AGM we also ratified the selection of Yvonne Perrie (Strathclyde University) and Michael Leane (BMS) as the incoming Board members. We warmly welcome them to the Board and look forward to working with them.
Follow us
 
Upcoming Events
APS Developability Workshop
22 - 23 March 2017
APS Industrial Insights 2017
20 - 21 April 2017
APS Board and Advisory Board Meeting
12 July 2017
APS 8th International PharmSci Conference 2017
5 - 7 September 2017
APS Amorphous meeting
3 October 2017
Job Vacancies
View all Vacancies
Advertise your job vacancies
The APS is grateful for the support of:
Join Us

Join the academy and get discounts on events, post-nominals, latest news and more.

 

The Academy of Pharmaceutical Sciences
Unit Q, Troon Way Business Centre
Humberstone Lane, Leicester, LE4 9HA
Tel: 0116 274 7351
Fax: 0116 274 7365
Email: info@apsgb.org

Terms of use:
The material included on this site is provided for information purposes only, and we make no representations or warranties as to its accuracy. Before relying on this material, you should take care to verify its accuracy, taking professional advice as appropriate.